Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study. Read more about Prognostic significance of plasma chromogranin a levels in patients with hormone-refractory prostate cancer treated in Cancer and Leukemia Group B 9480 study.
Failed percutaneous balloon dilation for renal access: incidence and risk factors. Read more about Failed percutaneous balloon dilation for renal access: incidence and risk factors.
Effect of vascular endothelial growth factor on regeneration of bladder acellular matrix graft: histologic and functional evaluation. Read more about Effect of vascular endothelial growth factor on regeneration of bladder acellular matrix graft: histologic and functional evaluation.
Multidisciplinary management of advanced prostate cancer: changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials. Read more about Multidisciplinary management of advanced prostate cancer: changing perspectives on referring patients and enhancing collaboration between oncologists and urologists in clinical trials.
Laparoscopic management of peripelvic renal cysts: University of California, San Francisco, experience and review of literature. Read more about Laparoscopic management of peripelvic renal cysts: University of California, San Francisco, experience and review of literature.
Androgen, estrogen, and progesterone receptor gene regulation during diabetic erectile dysfunction and insulin treatment. Read more about Androgen, estrogen, and progesterone receptor gene regulation during diabetic erectile dysfunction and insulin treatment.
Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer. Read more about Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer.
Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results. Read more about Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results.
Impact of race on survival in men with metastatic hormone-refractory prostate cancer. Read more about Impact of race on survival in men with metastatic hormone-refractory prostate cancer.
Value of urinary cytology in the diagnosis and management of urinary tract malignancies. Read more about Value of urinary cytology in the diagnosis and management of urinary tract malignancies.
